Prostate cancer reactivates developmental epigenomic programs during metastatic progression
Mark M. Pomerantz, Xintao Qiu, Yanyun Zhu, David Y. Takeda, Wenting Pan, Sylvan C. Baca, Alexander Gusev, Keegan Korthauer, Tesa Severson, Gavin Ha, Srinivas R. Viswanathan, Ji-Heui Seo, Holly M. Nguyen, Baohui Zhang, Bogdan Paşaniuc, Claudia Giambartolomei, Sarah Abou Alaiwi, Connor Bell, Edward O’Connor, Matthew Chabot, David R. Stillman, Rosina T. Lis, Alba Font‐Tello, Lewyn Li, Paloma Cejas, Andries M. Bergman, Joyce Sanders, Henk G. van der Poel, Simon A. Gayther, Kate Lawrenson, Marcos A. Fonseca, Jessica Reddy, Rosario I. Corona, Gleb Martovetsky, Brian Egan, Toni K. Choueiri, Leigh Ellis, Isla P. Garraway, Gwo‐Shu Mary Lee, Eva Corey, Henry W. Long, Wilbert Zwart, Matthew L. Freedman
Topics & Concepts
FOXA1EpigenomicsBiologyProstate cancerEpigeneticsTranscription factorProstateMetastasisCancer researchEpigenomeReprogrammingGeneticsCancerBioinformaticsDNA methylationGeneGene expressionProstate Cancer Treatment and ResearchEpigenetics and DNA MethylationCancer-related gene regulation